Clearmind Medicine Inc (CMND)

[levi]

It’s a race tpst is in the lead lol

[subslover]

I got in TPST A>H yesterday @ .88 and this morning in pre-market it dropped to .76 lol. I'm out man! 1,100 % LOL Amazing to even say the least.

I forgot all about CMND and thanks for the heads up. That was really nice of you. Will be checking her out again :)

[makinezmoney]

$CMND: Everyone watching $TPST today................... but here............

$CMND on a roll too now........................... tapping $0.27


Nice 79% mover so far


GO $CMND

[willlbone]

Dilution. Bid 10 cents.

[81vette]

Gap filled,back in for me.ZERO BORROW,no options

[Jmc1299]

Tomorrow is probably a good opportunity to buy the dump and make a few pennies

[AJ Freely]

$CMND - 👆Up 7.1% Pre-Market/ Current Price $0.49
Files US Patent Application For Dyskinesia Treatment, Strengthening Its IP

[Triple nickle]

Added

[Triple nickle]

Get that green wick under that green candle and we’re good

[Triple nickle]

Grabbed a starter

[subslover]

PRE MARKET SHOWING STRONG VOLUMES

[81vette]

48% win/banked,ZERO BORROW currently is great,big pop and drops in past,awaiting the next one,4-5 day pattern

[tw0122]

Chart recovery and older news…

The company filed a provisional patent application with the United States Patent and Trademark Office (USPTO) as part of its ongoing collaboration with SciSparc Ltd. (Nasdaq: SPRC) ("SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat central nervous system disorders.

This patent is an addition to Clearmind's robust intellectual property portfolio that includes patents for MEAI as a binge behavior regulator, as an alcoholic beverage substitute and others.

The patent application refers to novel proprietary combinations of MEAI and SciSparc's Palmitoylethanolamide (PEA), the active ingredient of its proprietary CannAmide™. It demonstrates Clearmind’s corporate mission to broaden the therapeutic psychedelic toolbox for patients with mental health disorders who await treatments with increased efficacy and safety while reducing cost.

Clearmind has a broad IP footprint in the psychedelic space with 24 patents in 14 patent families, nine of which have been granted in major jurisdictions like the US, Europe, China, and India. The company has already filed patent applications for the combination of Clearmind's MEAI with SciSparc's PEA compound for treating alcohol use disorder, cocaine addiction, and obesity and its related metabolic disorders.

[power11]

AND THERE GOES THE DUUUUUUUUUUUUUUUUUUUUUUUUUUMP !!
PENNYLAND PUMP AND DUMP !!!

[power11]

I DON'T THINK SO.....MORE LIKE PUMP AND DUMP !!!!

[81vette]

10 mms stacked at bid loading all the shares they can get,while holding it down at ask with few shares that remain,churn babe churn and supply will go dry

[81vette]

Many events inbound,3 patents coming with collaboration deal also(scisparc)

[81vette]

FDA approval Deadline tomorrow, alcoholism treatment!!!

[81vette]

Candle is all green and blue today,institutional/insiders buying today

[81vette]

ZERO BORROW,no shares to short,big buys usually follow,buckle up

[subslover]

Soaring pre market

[Pisd]

Sold for loss..good thing: https://ih.advfn.com/stock-market/NASDAQ/clearmind-medicine-CMND/stock-news/90691592/clearmind-medicine-announces-pricing-of-us-3-5-mil

[Pisd]

Buyer today for trade.. CMND$...

[Pisd]

idk?, maybe technical traders, watching.. gl, CMND$...

[RAlbert]

Is it another short squeeze opportunity or genuine price?

[Pisd]

Big run premarket..passed on $3's last week, gl..CMND$...

[QuicKtip]

Hebrew University' Yissum and Israeli Biotech Clearmind Medicine’s (NASDAQ, CSE: $CMND) (FSE: $CWY) Psychedelic-Derived Obesity Treatment Presented by Professor Joseph Tam, D.M.D., Ph.D. at Isranalytica 2023!

press release here: https://finance.yahoo.com/news/hebrew-university-yissum-israeli-biotech-133000128.html

[pantherj]

What's up here? It stinks to high heaven and reekis of scam.

[Raphael De La Ghetto]

I love dirt roads!

[tradernewstip]

$CMND News! Clearmind Medicine Inc. (Nasdaq:CMND) Achieves Major Milestone: Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial NEWS: https://yhoo.it/3X1lU7c

[r2g2]

This is supposed to have some legs. I guess we'll see.